Surface Pharmaceuticals Competitors and Similar CompaniesClear all

Surface Pharmaceuticals's competitors and similar companies include Eyevance Pharmaceuticals, Cipla, UCB and Genentech.

	Surface Pharmaceuticals Surface Pharmaceuticals is a biopharmaceutical company specializing in ocular surface disease.	Eyevance Pharmaceuticals Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2017	Founding Date 2017	Founding Date 1935	Founding Date 1928	Founding Date 1976
Type	Type Private	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development optics pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations HQ	Locations Fort Worth, US HQ Fort Worth, US	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 6	Employees 3716% decrease	Employees 27,764	Employees 9,052	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income €1.6b (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 21m (almost 8 years ago)	Latest funding round $ 30k (over 6 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 41m	Total funding raised $ 30k	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A